Stockreport

Merck Maintains Status In Front-Line Cancer Space [Seeking Alpha]

Merck & Company, Inc. (new)  (MRK) 
Last merck & company, inc. (new) earnings: 4/28 06:45 am Check Earnings Report
US:NYSE Investor Relations: investors.merck.com/home/default.aspx
PDF Merck Maintains Status In Front-Line Cancer Space Summary Merck announced FDA approval for Keytruda given in combination with Pfizer's Inlyta to treat front-line advance [Read more]